State of Possible 2024: Rewriting What is Possible
Featured in this panel are
Abe Ceesay, CEO, Rapport Therapeutics
Emma Lees, Ph.D., Sr. Vice President of Research & Early Development, Bristol Myers Squibb
Jacob Petersen, SVP, Head of Global Nucelic Acid Therapies, Novo Nordisk
Stan Wang, MD, Ph. D., CEO & Founder, Thymmune Therapeutics
Chris Garabedian, CEO, Xontogeny - Moderator